TrialArthritis research & therapy2014

Adalimumab serum levels and antidrug antibodies towards adalimumab in peripheral spondyloarthritis: no association with clinical response to treatment or with disease relapse upon treatment discontinuation.

Jacqueline E Paramarta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.